Keywords: astrazeneca, retains, patent, nolvadex, federal, district, court

AstraZeneca retains US patent on Nolvadex

Article | 20 September 2000

Print This

The Federal District Court in Boston, USA, has ruled that AstraZeneca'sUS patent covering its leading breast cancer drug Nolvadex (tamoxifen) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in